Myelodysplastic Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT
Conditions:   Allogeneic Hematopoietic Stem Cell Transplantation;   Acute Myeloid Leukemia;   Myelodysplastic Syndrome Intervention:   Drug: VEN+AZA+Modified BUCY Sponsor:   The First Affiliated Hospital of Soochow University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 21, 2023 Category: Research Source Type: clinical trials

Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes
Condition:   Untreated Myelodysplastic Syndrome Intervention:   Drug: Onureg + Venetoclax Sponsors:   Groupe Francophone des Myelodysplasies;   Bristol-Myers Squibb;   AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2023 Category: Research Source Type: clinical trials